References
  1. Hall TS, Brevetti GR, Skoultchi AJ, et al. Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes.Ann Thorac Cardiovasc Surg. 2001,7(6):352-357.
  2. Čanádyová J, Zmeko D, Mokráček A. Re‑exploration for bleeding or tamponade after cardiac operation. Interact Cardiovasc Thorac Surg. 2012, 14(6): 704‑707.
  3. Biancari F, Mikkola R, Heikkinen J, et al. Estimating the risk of complications related to re-exploration for bleeding after adult cardiac surgery: a systematic review and meta-analysis.Eur J Cardiothorac Surg. 2012,41(1):50-55.
  4. Ranucci M, Bozzetti G, Ditta A, et al. Surgical reexploration after cardiac operations: why a worse outcome?[J]. Ann Thorac Surg, 2008, 86(5): 1557‑1562.
  5. Karthik S, Grayson AD, McCarron EE,et al. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg. 2004,78(2):527-534.
  6. Haneya A, Diez C, Kolat P, et al.Re-exploration for bleeding or tamponade after cardiac surgery: impact of timing and indication on outcome.Thorac Cardiovasc Surg. 2015,63(1):51-57.
  7. Mehta RH, Sheng S, O′Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes, 2009, 2(6): 583‑590.
  8. LaPar DJ, Isbell JM, Mulloy DP,et al. Planned cardiac reexploration in the intensive care unit is a safe procedure.Ann Thorac Surg, 2014,98(5):1645-1651.
  9. Crawford TC, Magruder JT, Grimm JC, et al. Planned versus unplanned reexplorations for bleeding: a comparison of morbidity and mortality. Ann Thorac Surg, 2017, 103(3): 779‑786.
  10. Fröjd V, Jeppsson A. Reexploration for bleeding and its association with mortality after ardiac surgery. Ann Thorac Surg, 2016, 102(1): 109‑117.
  11. Tan TW, Kalish JA, Hamburg NM, et al. Shorter duration of femoral-popliteal bypass is associated with decreased surgical site infection and shorter hospital length of stay.J Am Coll Surg. 2012, 215(4):512-518.
  12. Maggino L, Liu JB, Ecker BL, et al. Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database.J Am Coll Surg. 2018,226(5):844-857.
  13. Short HL, Fevrier HB, Meisel JA, et al. Defining the association between operative time and outcomes in children′s surgery. J Pediatr Surg, 2017, 52(10):1561‑1566.
  14. Biancari F, Mikkola R, Heikkinen J, et al. Individual surgeon’s impact on the risk of re-exploration for excessive bleeding after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2012, 26(4):550-556.
  15. Kraut JA, Madias NE. Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol. 2012, 8(10):589-601.
  16. Kanazawa T, Egi M, Shimizu K, et al. Intraoperative change of lactate level is associated with postoperative outcomes in pediatric cardiac surgery patients: retrospective observational study. BMC Anesthesiol. 2015, 15:29.
  17. Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017,13(11):697-711.
  18. Guan C, Li C, Xu L, et al. Risk factors of cardiac surgery-associated acute kidney injury: development and validation of a perioperative predictive nomogram. J Nephrol. 2019, 32(6):937-945.
  19. Aboul‑Hassan SS, Stankowski T, Marczak J, et al. The use of preoperative aspirin in cardiac surgery: a systematic review and meta‑analysis. J Card Surg, 2017,32(12):758‑774.
  20. Ma X, Ma C, Yun Y, et al. Safety and efficacy outcomes of preoperative aspirin in patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis.J Cardiovasc Pharmacol Ther. 2014,19(1):97-113.